Reta — existing catalog illustration
Existing catalog illustration. A pictured label is not a batch result and may differ from the selected specification.

Modified peptide / Technical specification brief

Reta

Reta is used here as a catalog shorthand for retatrutide, a peptide investigated at GIP, GLP-1 and glucagon receptors.

MATERIALReta
SPECIFICATION4 catalog options
DOCUMENT SCOPEConfirm the offered lot
USELaboratory research only
Catalog specification — select for your inquiry

Selected: 10 mg

Nominal catalog options, not a live availability guarantee. Final supply is confirmed in the written quotation.

01 / Identity

Identity brief

Reta is used here as a catalog shorthand for retatrutide, a peptide investigated at GIP, GLP-1 and glucagon receptors.

Define the required Reta material before deciding between catalog supply and a custom project. A change in sequence, chemical form, conjugation or composition is a specification change, not simply a different pack size.

The key distinction
Keep the catalog reference, full material name, modification specification and requested amount together. Confirm any proposed substitution rather than relying on an abbreviation.

Scientific context

Research basis

The three-receptor research context distinguishes retatrutide from single- or dual-receptor molecules. Published studies do not certify a supplier's batch or establish a research vial as a trial formulation.

01

Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.

The New England journal of medicine · 2023 · PMID 37366315

Read the named material, experimental model, controls and limitations in the original paper. This source is scientific background, not a certificate for the offered lot.

Read the primary publication ↗
02

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.

Lancet (London, England) · 2023 · PMID 37385280

Read the named material, experimental model, controls and limitations in the original paper. This source is scientific background, not a certificate for the offered lot.

Read the primary publication ↗

For laboratory research use only. Not for human or veterinary use, diagnosis or therapeutic application. No administration or dosing protocol is provided.

Catalog & quotation

Technical specification

Catalog materialReta
Material classModified peptide
Listed options10 mg
25 mg
50 mg
100 mg
Catalog reference CAS2381089-83-2Reference field only; confirm it matches the supplied form.
Catalog reference formulaC221H342N46O68Reference field only; confirm it matches the supplied form.
Catalog reference molecular weight4731.4 g/molReference field only; confirm it matches the supplied form.
Identity / supplied formKeep the catalog reference, full material name, modification specification and requested amount together. Confirm any proposed substitution rather than relying on an abbreviation.
Identity, purity and contentRequest the method, acceptance specification and lot-specific results. Chromatographic purity and net material content are separate measurements.
Storage / stabilityFollow the written instructions for the actual material and batch. No universal 24-month shelf life or solution stability is assumed.
Catalog options are inquiry specifications, not a live stock feed. The final quotation must confirm the material, amount, packaging and document scope.

Evidence for the offered material

Analytical requirements

Confirm document availability for the actual material and lot. A catalog purity target or packaging label is not a released batch result.

Identity

Keep the catalog reference, full material name, modification specification and requested amount together. Confirm any proposed substitution rather than relying on an abbreviation.

Analytical scope

Ask which tests and underlying files are available, what each result measures and which batch it covers. Do not infer a test result from an image or badge.

Order match

Match product name, selected specification, lot reference and packaging to the quotation. Ask about any difference before confirming supply.

Before you inquire

Project questions

Can Reta and Retatrutide orders be combined automatically?

Keep the catalog reference, full material name, modification specification and requested amount together. Confirm any proposed substitution rather than relying on an abbreviation.

What should my Reta inquiry include?

Include the exact material name, the catalog option or required specification, quantity, destination and any documents needed before quotation. Keep nominal amount per container separate from the number of containers.

Does the catalog image confirm the selected specification?

No. It is a catalog illustration. The image may show one variant while the selector lists other options. Use the written quotation and matching batch documents to confirm supply.

Does a paper or an existing report validate every future batch?

No. A paper describes its studied material and model. An analytical report describes a named sample. Confirm the connection between any report and the lot offered for your order.

Catalog content reviewed 26 September 2026. Listed options are from this site's product records. Scientific sources, where shown, describe research context, not batch certification.

Start with the specification.

Include the material, amount and evidence your laboratory needs to review.

Prepare an inquiry